Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long-term outcomes of evolving treatment regimens in Ewing sarcoma survivors diagnosed 1970-1999: A report from the Childhood Cancer Survivor Study.

Cancer·2026
Same author

Modeling long-term mortality and morbidity in pediatric Hodgkin lymphoma survivors after reduced radiotherapy exposure.

Journal of the National Cancer Institute·2026
Same author

Potential for risk reduction of chronic health conditions through lifestyle in childhood cancer survivors.

Nature communications·2026
Same author

Cancer Treatment-Related Cardiotoxicity among Survivors of Childhood Cancer: A Comparative and Integrated View of Multiple Measures of Biological Age Acceleration.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·2026
Same author

Therapy-related mutational signatures in subsequent neoplasms among survivors of childhood cancer.

Cancer discovery·2026
Same author

Late complications of treatment for childhood pelvic sarcoma: A report from the Childhood Cancer Survivor Study (CCSS).

Journal of pediatric surgery·2026

Related Experiment Video

Updated: Jul 2, 2026

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
06:20

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition

Published on: March 11, 2021

Establishing action levels for EPID-based QA for IMRT.

Rebecca M Howell1, Iris P N Smith2, Christie S Jarrio2

  • 1Department of Radiation Physics, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, U.S.A.

Journal of Applied Clinical Medical Physics
|August 22, 2008
PubMed
Summary

Portal dosimetry quality assurance (QA) for intensity-modulated radiation therapy (IMRT) plans is crucial. This study established clinical action levels for IMRT QA, finding that lower dose rates improve agreement between predicted and measured doses.

More Related Videos

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy
08:17

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy

Published on: June 7, 2015

Radiation Planning Assistant - A Streamlined, Fully Automated Radiotherapy Treatment Planning System
08:25

Radiation Planning Assistant - A Streamlined, Fully Automated Radiotherapy Treatment Planning System

Published on: April 11, 2018

Related Experiment Videos

Last Updated: Jul 2, 2026

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
06:20

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition

Published on: March 11, 2021

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy
08:17

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy

Published on: June 7, 2015

Radiation Planning Assistant - A Streamlined, Fully Automated Radiotherapy Treatment Planning System
08:25

Radiation Planning Assistant - A Streamlined, Fully Automated Radiotherapy Treatment Planning System

Published on: April 11, 2018

Area of Science:

  • Medical Physics
  • Radiation Oncology
  • Radiotherapy Quality Assurance

Background:

  • Portal dosimetry is essential for quality assurance (QA) in intensity-modulated radiation therapy (IMRT).
  • Understanding trends in agreement between portal dose prediction (PDP) and measured dose is critical for refining QA protocols.
  • Existing QA methods require standardization for reliable evaluation of IMRT treatment plans.

Purpose of the Study:

  • To evaluate agreement between portal dose prediction (PDP) and measured dose using scalar parameters for IMRT QA.
  • To establish clinical action levels for IMRT QA based on institutional data.
  • To investigate the impact of dose rate on the agreement between predicted and measured portal doses.

Main Methods:

  • Evaluation of three agreement parameters: maximum gamma (gamma max), average gamma (gamma avg), and percentage of field area with gamma > 1.0 (gamma % > 1).
  • Analysis of 152 IMRT treatment plans, comprising 1152 treatment fields.
  • Recalculation of fields at lower dose rates to assess impact on dose agreement.

Main Results:

  • Established clinical action levels for IMRT QA using mean and standard deviations of agreement parameters.
  • Demonstrated improved agreement between measured dose and PDP when fields were recalculated at lower dose rates.
  • Quantified agreement using gamma max, gamma avg, and gamma % > 1.0.

Conclusions:

  • Clinical action levels provide a standardized approach for evaluating EPID-based IMRT QA.
  • Lowering dose rates during recalculation enhances the accuracy of portal dose predictions.
  • The established action levels facilitate consistent and reliable QA for IMRT treatment plans.